Literature DB >> 15791441

Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.

Miguel Hernandez-Pampaloni1, Jeroen J Bax, Koichi Morita, David P Dutka, Paolo G Camici.   

Abstract

PURPOSE: Different criteria to identify residual viability in chronically dysfunctioning myocardium in patients with coronary artery disease (CAD) can be derived by the combined assessment of myocardial blood flow (MBF) and glucose utilisation (MRG) using positron emission tomography (PET). The aim of this study was to evaluate, in a large number of patients, the prevalence of these different patterns by purely quantitative means.
METHODS: One hundred and sixteen consecutive patients with ischaemic cardiomyopathy (LVEF < or =40%) underwent resting 2D echocardiography to assess regional contractile function (16-segment model). PET with 15O-labelled water (H2 15O) and 18F-fluorodeoxyglucose (FDG) was used to quantify MBF and MRG during hyperinsulinaemic euglycaemic clamp. Dysfunctional segments with normal MBF (> or =0.6 ml min(-1) g(-1)) were classified as stunned, and segments with reduced MBF (<0.6 ml min(-1) g(-1)) as hibernating if MRG was > or =0.25 micromol min(-1) g(-1). Segments with reduced MBF and MRG <0.20 micromol min(-1) g(-1) were classified as transmural scars and segments with reduced MBF and MRG between 0.20 and 0.25 micromol min(-1) g(-1) as non-transmural scars.
RESULTS: Eight hundred and thirty-four (46%) segments were dysfunctional. Of these, 601 (72%) were chronically stunned, with 368 (61%) having normal MRG (0.47+/-0.20 micromol min(-1) g(-1)) and 233 (39%) reduced MRG (0.16+/-0.05 micromol min(-1) g(-1)). Seventy-four (9%) segments with reduced MBF had preserved MRG (0.40+/-0.18 micromol min(-1) g(-1)) and were classified as hibernating myocardium. In addition, 15% of segments were classified as transmural and 4% as non-transmural scar. The mean MBF was highest in stunned myocardium (0.95+/-0.32 ml min(-1) g(-1)), intermediate in hibernating myocardium and non-transmural scars (0.47+/-0.09 ml min(-1) g(-1) and 0.48+/-0.08 ml min(-1) g(-1), respectively), and lowest in transmural scars (0.40+/-0.14 ml min(-1) g(-1), P<0.01). MRG was comparable in hibernating and stunned myocardium with preserved MRG (0.40+/-0.19 micromol min(-1) g(-1) vs 0.46+/-0.20 micromol min(-1) g(-1), NS), and lowest in stunned myocardium with reduced MRG and transmural scars.
CONCLUSION: Chronic stunning is more prevalent than expected. The degree of MRG reduction in stunned myocardium may disclose segments at higher risk of permanent damage.

Entities:  

Mesh:

Year:  2004        PMID: 15791441     DOI: 10.1007/s00259-004-1682-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  38 in total

1.  Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium.

Authors:  J J Bax; D Poldermans; A Elhendy; E Boersma; S H Rahimtoola
Journal:  Curr Probl Cardiol       Date:  2001-02       Impact factor: 5.200

2.  Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.

Authors:  N V Marinho; B E Keogh; D C Costa; A A Lammerstma; P J Ell; P G Camici
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 4.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

5.  13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization.

Authors:  A N Kitsiou; S L Bacharach; M L Bartlett; G Srinivasan; R M Summers; A A Quyyumi; V Dilsizian
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

Review 6.  Measurements of myocardial metabolism in patients with ischemic heart disease.

Authors:  H R Schelbert
Journal:  Am J Cardiol       Date:  1998-09-03       Impact factor: 2.778

7.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.

Authors:  F Haas; C J Haehnel; W Picker; S Nekolla; S Martinoff; H Meisner; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

8.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

9.  Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease.

Authors:  P Perrone-Filardi; S L Bacharach; V Dilsizian; J A Marin-Neto; S Maurea; J A Arrighi; R O Bonow
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

10.  Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest.

Authors:  James A Fallavollita; Brian J Malm; John M Canty
Journal:  Circ Res       Date:  2003-01-10       Impact factor: 17.367

View more
  6 in total

1.  Assessment of myocardial viability by nuclear imaging techniques.

Authors:  Jeroen J Bax; Don Poldermans; Abdou Elhendy; Eric Boersma; Ernst E van der Wall
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

2.  In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.

Authors:  Andrei Todica; Mathias J Zacherl; Hao Wang; Guido Böning; Nathalie L Jansen; Carmen Wängler; Peter Bartenstein; Michael C Kreissl; Marcus Hacker; Stefan Brunner; Sebastian Lehner
Journal:  J Nucl Cardiol       Date:  2014-09-05       Impact factor: 5.952

3.  Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Authors:  Javier E Lopez; Khung Yeo; Gary Caputo; Michael Buonocore; Saul Schaefer
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-11       Impact factor: 5.364

4.  Conditional HIF-1alpha expression produces a reversible cardiomyopathy.

Authors:  Raffi Bekeredjian; Chad B Walton; Keith A MacCannell; Jennifer Ecker; Fred Kruse; Joel T Outten; David Sutcliffe; Robert D Gerard; Richard K Bruick; Ralph V Shohet
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

Review 5.  Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure.

Authors:  Yuri Sheikine; Marcelo F Di Carli
Journal:  Curr Heart Fail Rep       Date:  2008-09

Review 6.  Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts?

Authors:  J J Bax; R S Beanlands; F J Klocke; J Knuuti; A A Lammertsma; M A Schaefers; H R Schelbert; G K Von Schulthess; L J Shaw; G Z Yang; P G Camici
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.